Young Peter 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Jan 5, 2009
Insider Transaction Report
Form 4
Young Peter
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2009-01-05$0.20/sh−10,000$2,000→ 0 totalExercise: $0.41Exp: 2018-06-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option, which provided for vesting on the first anniversary of the grant date, was canceled in connection with the Issuer's merger with 900 North Point Acquisition Corporation on January 5, 2009. In exchange, the Reporting Person received a cash payment of $2,000, which represents the difference between the exercise price of the option and the offer price of $0.61 per share multiplied by the number of shares underlying the option.